Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2004 | 12-2003 | 09-2003 | 06-2003 | 03-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -50,350 | -44,330 | -37,120 | N/A |
| Depreciation Amortization | N/A | 9,420 | 7,150 | 5,150 | N/A |
| Other Working Capital | N/A | -32,160 | -12,310 | -6,620 | N/A |
| Other Operating Activity | 0 | 4,700 | -7,630 | -5,340 | 0 |
| Operating Cash Flow | $N/A | $-68,390 | $-57,120 | $-43,930 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -3,830 | -2,710 | -1,350 | N/A |
| Other Investing Activity | 0 | -19,490 | -18,010 | -4,430 | 0 |
| Investing Cash Flow | $N/A | $-23,320 | $-20,720 | $-5,780 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 3,660 | 2,290 | 550 | 0 |
| Financing Cash Flow | $N/A | $3,660 | $2,290 | $550 | $N/A |
| Exchange Rate Effect | N/A | 1,170 | 900 | 540 | N/A |
| Beginning Cash Position | N/A | 117,070 | 117,070 | 117,070 | N/A |
| End Cash Position | N/A | 30,180 | 42,430 | 68,460 | N/A |
| Net Cash Flow | $N/A | $-86,890 | $-74,640 | $-48,610 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -68,390 | -57,120 | -43,930 | N/A |
| Free Cash Flow | 0 | -68,390 | -57,120 | -43,930 | 0 |